Elekta AB (EKTAY)
6.85
+0.15
(+2.24%)
USD |
OTCM |
Apr 26, 11:47
Elekta Cash from Financing (TTM): -4.613M for Jan. 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -4.613M |
October 31, 2023 | -15.06M |
July 31, 2023 | -14.08M |
April 30, 2023 | -12.40M |
January 31, 2023 | -271.64M |
October 31, 2022 | -115.63M |
July 31, 2022 | -147.96M |
April 30, 2022 | -194.73M |
January 31, 2022 | -94.87M |
October 31, 2021 | -261.32M |
July 31, 2021 | -458.15M |
April 30, 2021 | -412.68M |
January 31, 2021 | 19.20M |
October 31, 2020 | 32.80M |
July 31, 2020 | 270.26M |
April 30, 2020 | 272.87M |
January 31, 2020 | -86.24M |
October 31, 2019 | -128.18M |
July 31, 2019 | -115.29M |
April 30, 2019 | -163.22M |
January 31, 2019 | -148.51M |
October 31, 2018 | -99.22M |
July 31, 2018 | -97.01M |
April 30, 2018 | -44.28M |
January 31, 2018 | -15.25M |
Date | Value |
---|---|
October 31, 2017 | -16.25M |
July 31, 2017 | -3.716M |
April 30, 2017 | -6.302M |
January 31, 2017 | -17.58M |
October 31, 2016 | -15.33M |
July 31, 2016 | -152.46M |
April 30, 2016 | -154.73M |
January 31, 2016 | -21.93M |
October 31, 2015 | -4.976M |
July 31, 2015 | 21.97M |
April 30, 2015 | 25.04M |
January 31, 2015 | -109.10M |
October 31, 2014 | -121.11M |
July 31, 2014 | -116.16M |
April 30, 2014 | -136.17M |
January 31, 2014 | -115.55M |
October 31, 2013 | -131.07M |
July 31, 2013 | -80.72M |
April 30, 2013 | -57.00M |
January 31, 2013 | 104.84M |
October 31, 2012 | 117.45M |
July 31, 2012 | 264.62M |
April 30, 2012 | 480.10M |
January 31, 2012 | 299.05M |
October 31, 2011 | 298.77M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-458.15M
Minimum
Jul 2021
272.87M
Maximum
Apr 2020
-95.05M
Average
-105.08M
Median
Cash from Financing (TTM) Benchmarks
Abliva AB | 0.0391M |
Karolinska Development AB | -0.0758M |
Calliditas Therapeutics AB | -- |
Oncopeptides AB | 11.82M |
Olink Holding AB | 92.50M |